Table 3.

Baseline measures of cognitive performance (dichotomized into Low (n = 31) and High (n = 21) groups based on median score) vs. PA adherence

	3MSE			Stroop			DSST			RAVLT
Phaseˆ	Low	High	P-value	Low	High	P-value	Low	High	P-value	Low	High	P-value
Transition	64.5 ± 25.5	67.1 ± 29.6	0.49	64.2 ± 28.3	65.8 ± 26.1	0.61	65.1 ± 26.4	66.1 ± 28.3	0.87	68.7 ± 20.3	60.9 ± 34.6	0.65
Adoption	82.2 ± 15.2	76.1 ± 24.1	0.34	77.7 ± 22.9	80.9 ± 15.3	0.41	81.1 ± 15.2	77.7 ± 24.4	0.45	81.3 ± 17.1	77.4 ± 22.4	0.92
Combined	72.5 ± 19.2	72.1 ± 24.5	0.82	70.4 ± 25.0	73.3 ± 17.3	0.44	72.9 ± 19.3	71.5 ± 24.4	0.79	74.6 ± 16.3	69.1 ± 27.1	0.78

Values mean ± SD, P values (Low vs. High) are adjusted for clinical site and gender; ˆAdoption phase of the intervention is weeks 1–8; ˆTransition phase of the intervention is weeks 9–24; ˆCombined is the adoption + transition (weeks 1–24)